Navigation Links
Cancer Patients in New South Wales to Receive Advanced Image Guided Radiation Therapy Treatments

North Coast Cancer Institute (NCCI) Coffs Harbour and Port Macquarie began providing radiotherapy treatment services for the first time in the North Coast region of New South Wales, Australia .

Cancer patients in New South Wales now have access to state-of-the-art treatments as the latest in image-guided radiation therapy ( IGRT) equipment from Elekta went clinical at both sites. The first treatment was a major step for a small centre introducing complex treatment technologies such as IMRT and IGRT on an Elekta Synergy(R) system advanced digital linear accelerator, supported by IMPAC MOSAIQ(TM) Oncology information system. The first patient treated had intermediate risk prostate cancer and was planned with MRI-CT fusion and fiducial marker insertion, and treated with dose-escalated 7-field IMRT with online cone-beam CT and electronic portal image verification.

"As a result of the technology now available at the NCCI, we will be able to provide patients with the most modern, highest quality radiation oncology treatment available in Australia," said Area Director of Cancer Services A. Prof. Tom Shakespeare. "What's really exciting is seeing this ground-breaking technology made available to smaller regional centres that have, until now, had no local access to radiotherapy. Even more impressive, is the fact that our team has been able to implement complex Intensity Modulated Radiotherapy Treatment modalities and adopt image guided treatment techniques from the start. This was accomplished in order to offer patients the highest possible quality of care. With the incredible support provided by Elekta, Coffs Harbour has evolved from a city without radiotherapy to a city with the highest quality radiotherapy in the region and our Port Macquarie centre also will start soon, offering the same impressive treatment capabilities. It is not surprising that we are now receiving referrals from across the state and even interstate."

Elekta Sy nergy was selected for the NCCI following a competitive tender process and is considered the market-leading IGRT solution, revolutionizing radiotherapy by offering integrated 3D volumetric imaging at the time of treatment. By imaging patients in the treatment position during the actual time of treatment, Elekta Synergy is able to offer significantly greater treatment accuracy and higher confidence that the intended therapeutic dose is delivered to the patient as planned.


'"/>




Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2017)... ... 23, 2017 , ... “Some Infallible Characteristics of Christ”: a fascinating and ... Christ” is the creation of published author, Rev. Dr. Robert W. Thomas, the third ... a preacher for over nineteen, a pastor for over fifteen years. He is a ...
(Date:1/22/2017)... TX (PRWEB) , ... January 22, 2017 , ... ... provide slow results. Often the results of a simple test will take days to ... Any Lab Test Now offers customers direct access to their lab tests, bypassing the ...
(Date:1/21/2017)... ... ... Phytocéane invites you to take an exotic journey deep into ... ZANZIBAR SHOWER GEL. Inspired by the beauty of Zanzibar, a Tanzanian archipelago off the ... coral to create this gentle, crystal-clear shower gel to cleanse the body and promote ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel Biocare™ dental ... in media for its creos™ line of bone regenerative products. Specifically, the ... which he utilizes creos™ allo.gain™ bone graft for a variety of bone reconstruction ...
(Date:1/20/2017)... ... 20, 2017 , ... Doctor C LLC, a company based out of Arizona ... to continue the marketing and distribution of its product, The Right C. , The ... better absorption than traditional vitamin C supplements. At the trade show, Doctor C had ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... The global  anxiety disorders and depression treatment market  is ... incidence of depression worldwide is anticipated to drive the market growth in the ... demand for antidepressants in the recent years. Continue ... ... ...
(Date:1/23/2017)... 23 janvier 2017  ResMed (NYSE : RMD), BMC (Pékin, ... ont annoncé aujourd,hui qu,ils se sont mis d,accord sur ... les parties. BMC et 3B seront autorisés à vendre ... à ResMed, et ResMed effectuera le paiement de la ... le litige de Floride entre les deux parties. Le ...
(Date:1/23/2017)... DIEGO , 23. Januar 2017  ResMed (NYSE: ... ) und 3B Medical ( Winter Haven, ... auf eine Vereinbarung über die Beilegung aller globalen Rechtsstreitigkeiten ... der Verkauf ihrer bestehenden Produkte im Tausch ... einmalige Zahlung an 3B leisten, um das in ...
Breaking Medicine Technology: